Atlas Trials

IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma

Clinical trial NCT01333605 · UNKNOWN

Trial details

NCT number
NCT01333605
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin Lymphoma
Start date
2011-04-01
Primary completion
2014-04-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.